Publications by authors named "Michael Yemma"

Claim this Profile
A
A FAK scaffold inhibitor disrupts FAK and VEGFR-3 signaling and blocks melanoma growth by targeting both tumor and endothelial cells.
Elena Kurenova, Deniz Ucar, Jianqun Liao, Michael Yemma, Priyanka Gogate

Cell Cycle· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting the C-terminal focal adhesion kinase scaffold in pancreatic cancer.
Priyanka N Gogate, Elena V Kurenova, Manivannan Ethirajan, Jianqun Liao, Michael Yemma

Cancer Lett· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MiR-138 and MiR-135 directly target focal adhesion kinase, inhibit cell invasion, and increase sensitivity to chemotherapy in cancer cells.
Vita M Golubovskaya, Brittany Sumbler, Baotran Ho, Michael Yemma, William G Cance

Anticancer Agents Med Chem· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The FAK scaffold inhibitor C4 disrupts FAK-VEGFR-3 signaling and inhibits pancreatic cancer growth.
Elena Kurenova, Jianqun Liao, Di-Hua He, Darrell Hunt, Michael Yemma

Oncotarget· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacologic blockade of FAK autophosphorylation decreases human glioblastoma tumor growth and synergizes with temozolomide.
Vita M Golubovskaya, Grace Huang, Baotran Ho, Michael Yemma, Carl D Morrison

Mol Cancer Ther· February 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A small molecule focal adhesion kinase (FAK) inhibitor, targeting Y397 site: 1-(2-hydroxyethyl)-3, 5, 7-triaza-1-azoniatricyclo [3.3.1.1(3,7)]decane; bromide effectively inhibits FAK autophosphorylation activity and decreases cancer cell viability, clonogenicity and tumor growth in vivo.
Vita M Golubovskaya, Sheila Figel, Baotran T Ho, Christopher P Johnson, Michael Yemma

Carcinogenesis· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis